Goelzer Investment Management, Inc. Pacira Bio Sciences, Inc. Transaction History

Goelzer Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$51.49 - $81.64 $14,932 - $23,675	290 Added 0.93%	31,495 $1.84 Million
Q1 2022 May 10, 2022	BUY	$60.03 - $76.49 $676,898 - $862,501	11,276 Added 56.58%	31,205 $2.38 Million
Q4 2021 Feb 11, 2022	SELL	$47.97 - $62.21 $34,922 - $45,288	-728 Reduced 3.52%	19,929 $1.2 Million
Q3 2021 Oct 29, 2021	SELL	$54.64 - $61.3 $29,724 - $33,347	-544 Reduced 2.57%	20,657 $1.16 Million
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $11,599 - $13,718	196 Added 0.93%	21,201 $1.29 Million
Q1 2021 May 06, 2021	SELL	$59.31 - $78.82 $68,858 - $91,510	-1,161 Reduced 5.24%	21,005 $1.47 Million
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $5,602 - $7,354	-111 Reduced 0.5%	22,166 $1.33 Million
Q3 2020 Oct 27, 2020	BUY	$51.97 - $63.0 $1.16 Million - $1.4 Million	22,277 New	22,277 $1.34 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Goelzer Investment Management, Inc. with notifications on news.